{"mainPropery":{"diseaseId":5429,"diseaseName":"Orotic aciduria type 1","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5429/orotic-aciduria-type-1","synonyms":["Orotidylic pyrophosphorylase and orotidylic decarboxylase deficiency","UMPS deficiency","Uridine monophosphate synthase deficiency","UMP synthtase deficiency","Orotate phosphoribosyltransferase and omp decarboxylase deficiency","UMPS","Uridine monophosphate synthetase deficiency","Hereditary orotic aciduria","Orotic aciduria II (formerly)","Oroticaciduria 1","Hereditary orotic aciduria without megaloblastic anemia"],"synonyms-with-source":[{"name":"Orotidylic pyrophosphorylase and orotidylic decarboxylase deficiency"},{"name":"UMPS deficiency"},{"name":"Uridine monophosphate synthase deficiency"},{"name":"UMP synthtase deficiency"},{"name":"Orotate phosphoribosyltransferase and omp decarboxylase deficiency"},{"name":"UMPS"},{"name":"Uridine monophosphate synthetase deficiency"},{"name":"Hereditary orotic aciduria"},{"name":"Orotic aciduria II (formerly)"},{"name":"Oroticaciduria 1"},{"name":"Hereditary orotic aciduria without megaloblastic anemia","source":"OMIM 258900"}],"identifiers":[{"identifierType":"OMIM","identifierId":"258900"},{"identifierType":"ORPHANET","identifierId":"30"},{"identifierType":"UMLS","identifierId":"C0268130"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"}],"organizations":[{"resourceID":945,"resourceName":"Human Growth Foundation","abbreviation":"","address1":"997 Glen Cove Avenue, Suite 5","address2":"","address3":"","address4":"","address5":"","city":"Glen Head","state":"NY","zip":"11545","country":"United States","phone":"","tty":"","tollFree":"1-800-451-6434","fax":"516-671-4055","email":"hgf1@hgfound.org","url":"http://www.hgfound.org/","freeText":""},{"resourceID":948,"resourceName":"Restricted Growth Association","abbreviation":"","address1":"P.O. Box 4744","address2":"Dorchester","address3":"Dorset, Intl DT2 9FA","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"01308 898445","tty":"","tollFree":"","fax":"01308 898445","email":"","url":"http://www.restrictedgrowth.co.uk","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/258900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=Orotic%20aciduria%5Bti%5D%20AND%20%28%22humans%22%5BMeSH%20Terms%5D%20AND%20English%5Blang%5D%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Orotic aciduria type 1. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":73,"resourceId":946,"resourceName":"National Anemia Action Council","descriptionText":"National Anemia Action Council, Inc.<br />555 E Wells St, Suite 1100 <br />Milwaukee, WI 53202 <br />Telephone: 414-225-0138 <br />Fax: 414-276-3349 <br />Ask the expert: <a href=\"http://www.anemia.org/professionals/asktheexpert/browse.php\" target=\"_blank\">http://www.anemia.org/professionals/asktheexpert/browse.php</a> Â <br />Web site: <a href=\"http://www.anemia.org/\" target=\"_blank\">http://www.anemia.org/</a> ","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Organizations Providing General Support"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=30' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:258900' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6110,"questionText":"What is orotic aciduria type I?","answerText":"<strong>Orotic aciduria type I</strong> (OA1), also known as hereditary orotic aciduria,&nbsp;is a rare condition characterized by elevated levels of orotic acid in the urine.[13805] It typically becomes apparent in the first months of life with&nbsp;<a href=\"https://medlineplus.gov/ency/imagepages/1214.htm\" target=\"_blank\">megaloblastic anemia</a>,&nbsp;as well as delays in physical and intellectual development.[13805][5139] OA1 is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the&nbsp;<a href=\"http://omim.org/entry/613891?search=UMPS&amp;highlight=umps\" target=\"_blank\"><em>UMPS</em></a>&nbsp;gene and inheritance is autosomal recessive. OA1 differs from other causes of orotic aciduria, which may include <a href=\"https://www.umdf.org/what-is-mitochondrial-disease/\" target=\"_blank\">mitochondrial disorders</a>, <a href=\"https://ghr.nlm.nih.gov/condition/lysinuric-protein-intolerance\" target=\"_blank\">lysinuric protein intolerance</a>, and <a href=\"https://medlineplus.gov/liverdiseases.html\" target=\"_blank\">liver disease</a>.[13805]<br />\r\n<br />\r\nTreatment involves taking uridine; <a href=\"https://medlineplus.gov/druginfo/meds/a616020.html\" target=\"_blank\">uridine triacetate</a> was granted FDA approval for treating OA1 in 2015.[13806] Without treatment, children with OA1 may experience <a href=\"http://www.mayoclinic.org/symptoms/neutropenia/basics/definition/sym-20050854\" target=\"_blank\">neutropenia</a>, <a href=\"https://medlineplus.gov/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a>, developmental delay, and intellectual disability.[13805]","dateModified":"2017-09-13T00:00:00"},"basicQuestions":[{"questionId":6111,"questionText":"How is&nbsp;orotic aciduria type I diagnosed?","answerText":"Orotic aciduria type I (OA1) is diagnosed by a urine test that reveals very high amounts of orotic acid, with milder elevations of orotidine. The respective amounts of these substances result in an OA/orotidine ratio of above 10.[13807] Genetic testing of the <em><a href=\"https://ghr.nlm.nih.gov/gene/UMPS\" target=\"_blank\">UMPS</a></em> gene is also available. A correct and timely diagnosis of OA1 is key to effective treatment for the condition.[13805]","dateModified":"2017-09-13T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":13805,"authors":"Wortmann SB, Chen MA, Colombo R, et al","articleTitle":"Mild orotic aciduria in UMPS heterozygotes: a metabolic finding without clinical consequences","bookWebsiteJournalTitle":"J Inherit Metab Dis","date":"May, 2017","volume":"40(3)","pages":"423-431","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393157/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13807,"authors":"Balasubramaniam S, Duley JA, Christodoulou J","articleTitle":"Inborn errors of pyrimidine metabolism: clinical update and therapy","bookWebsiteJournalTitle":"J Inherit Metab Dis","date":"September, 2014","volume":"37(5)","pages":"687-698","url":"https://www.ncbi.nlm.nih.gov/pubmed/25030255","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":34603,"abbreviatedInquiry":"How&nbsp;is orotic aciduria type I diagnosed?&nbsp; How is it treated?","caseQuestions":[{"questionId":6111,"questionText":"How is&nbsp;orotic aciduria type I diagnosed?","answerText":"Orotic aciduria type I (OA1) is diagnosed by a urine test that reveals very high amounts of orotic acid, with milder elevations of orotidine. The respective amounts of these substances result in an OA/orotidine ratio of above 10.[13807] Genetic testing of the <em><a href=\"https://ghr.nlm.nih.gov/gene/UMPS\" target=\"_blank\">UMPS</a></em> gene is also available. A correct and timely diagnosis of OA1 is key to effective treatment for the condition.[13805]","dateModified":"2017-09-13T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":13805,"authors":"Wortmann SB, Chen MA, Colombo R, et al","articleTitle":"Mild orotic aciduria in UMPS heterozygotes: a metabolic finding without clinical consequences","bookWebsiteJournalTitle":"J Inherit Metab Dis","date":"May, 2017","volume":"40(3)","pages":"423-431","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393157/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13807,"authors":"Balasubramaniam S, Duley JA, Christodoulou J","articleTitle":"Inborn errors of pyrimidine metabolism: clinical update and therapy","bookWebsiteJournalTitle":"J Inherit Metab Dis","date":"September, 2014","volume":"37(5)","pages":"687-698","url":"https://www.ncbi.nlm.nih.gov/pubmed/25030255","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":4003,"phenoTypeName":"Aminoaciduria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15539,"phenoTypeName":"Anemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13622,"phenoTypeName":"Orotic acid crystalluria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14519,"phenoTypeName":"Oroticaciduria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13334,"phenoTypeName":"Abnormal toenail morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9999,"phenoTypeName":"Abnormality of the ureter","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5603,"phenoTypeName":"Downslanted palpebral fissures","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5681,"phenoTypeName":"Hip dysplasia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10388,"phenoTypeName":"Hypertelorism","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8235,"phenoTypeName":"Impaired T cell function","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10438,"phenoTypeName":"Low-set, posteriorly rotated ears","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8975,"phenoTypeName":"Patent ductus arteriosus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8075,"phenoTypeName":"Recurrent respiratory infections","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10447,"phenoTypeName":"Wide nasal bridge","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4777,"phenoTypeName":"Atrial septal defect","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4775,"phenoTypeName":"Ventricular septal defect","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4376,"phenoTypeName":"Anisocytosis","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":10823,"phenoTypeName":"Folate-unresponsive megaloblastic anemia","percentRanges":"-"},{"phenoTypeId":14161,"phenoTypeName":"Hematuria","percentRanges":"-"},{"phenoTypeId":628,"phenoTypeName":"Hypochromia","percentRanges":"-"},{"phenoTypeId":9230,"phenoTypeName":"Poikilocytosis","percentRanges":"-"},{"phenoTypeId":3988,"phenoTypeName":"Pyrimidine-responsive megaloblastic anemia","percentRanges":"-"},{"phenoTypeId":10956,"phenoTypeName":"Reduced orotidine 5-prime phosphate decarboxylase level","percentRanges":"-"}],"medicalProducts":[{"productId":627,"genericName":"Uridine triacetate","tradeName":"Xuriden","tradeLink":"http://www.xuriden.com/","manufacturer":"","sponsor":"Wellstat Therapeutics, Inc.","indication":"Treatment of hereditary orotic aciduria.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/xuriden","medlinePlusLink":""}],"EncodedName":"Orotic_aciduria_type_1"}